Eloisa Lamas

433 total citations
15 papers, 249 citations indexed

About

Eloisa Lamas is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Gastroenterology. According to data from OpenAlex, Eloisa Lamas has authored 15 papers receiving a total of 249 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Gastroenterology. Recurrent topics in Eloisa Lamas's work include Helicobacter pylori-related gastroenterology studies (11 papers), Eosinophilic Esophagitis (5 papers) and Gastroesophageal reflux and treatments (4 papers). Eloisa Lamas is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (11 papers), Eosinophilic Esophagitis (5 papers) and Gastroesophageal reflux and treatments (4 papers). Eloisa Lamas collaborates with scholars based in Spain and Chile. Eloisa Lamas's co-authors include Manuel Castro‐Fernández, Ángeles Pérez‐Aísa, Ángel Cosme, Javier P. Gisbert, Felipe Bory, Miguel Fernández‐Bermejo, Fernando Bermejo, Luı́s Rodrigo, Inés Modolell and Xavier Calvet and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Eloisa Lamas

13 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eloisa Lamas Spain 6 215 114 86 74 35 15 249
İlkay Şımşek Türkiye 12 310 1.4× 149 1.3× 124 1.4× 68 0.9× 15 0.4× 25 372
C. De Giacomo Italy 8 214 1.0× 115 1.0× 36 0.4× 16 0.2× 24 0.7× 19 283
Iswan Abbas Nusi Indonesia 10 261 1.2× 74 0.6× 71 0.8× 60 0.8× 41 1.2× 31 319
Chrystian Dallaire Canada 7 159 0.7× 74 0.6× 78 0.9× 60 0.8× 12 0.3× 7 185
M. Hellblom Sweden 7 505 2.3× 314 2.8× 170 2.0× 135 1.8× 41 1.2× 8 552
F Sato Japan 5 350 1.6× 92 0.8× 79 0.9× 86 1.2× 8 0.2× 8 365
Joost Scherpenisse Netherlands 7 184 0.9× 29 0.3× 107 1.2× 32 0.4× 4 0.1× 10 247
Kalyanam Subramanyam United States 7 247 1.1× 54 0.5× 51 0.6× 66 0.9× 18 0.5× 14 321
S. Tchamgoué France 4 177 0.8× 87 0.8× 69 0.8× 67 0.9× 71 2.0× 9 249
O Cannizzaro Italy 7 285 1.3× 184 1.6× 121 1.4× 120 1.6× 39 1.1× 12 339

Countries citing papers authored by Eloisa Lamas

Since Specialization
Citations

This map shows the geographic impact of Eloisa Lamas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eloisa Lamas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eloisa Lamas more than expected).

Fields of papers citing papers by Eloisa Lamas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eloisa Lamas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eloisa Lamas. The network helps show where Eloisa Lamas may publish in the future.

Co-authorship network of co-authors of Eloisa Lamas

This figure shows the co-authorship network connecting the top 25 collaborators of Eloisa Lamas. A scholar is included among the top collaborators of Eloisa Lamas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eloisa Lamas. Eloisa Lamas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Gisbert, Javier P., Manuel Castro‐Fernández, Ángel Cosme, et al.. (2015). Su1131 Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures. Gastroenterology. 148(4). S–416. 1 indexed citations
2.
Gisbert, Javier P., Manuel Castro‐Fernández, Ángel Cosme, et al.. (2014). Su1175 Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures. Gastroenterology. 146(5). S–395. 1 indexed citations
3.
Gisbert, Javier P., Fernando Bermejo, Manuel Castro‐Fernández, et al.. (2013). Second-Line Rescue Therapy with Levofloxacin After Failure of Treatment to Eradicate Helicobacter Pylori Infection: Time Trends in a Spanish Multicenter Study of 1300 Patients. Helicobacter.
4.
Gisbert, Javier P., Manuel Castro‐Fernández, Ángeles Pérez‐Aísa, et al.. (2012). Fourth‐line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures. Alimentary Pharmacology & Therapeutics. 35(8). 941–947. 51 indexed citations
5.
Gisbert, Javier P., Ángeles Pérez‐Aísa, Fernando Bermejo, et al.. (2012). Second-line Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection. Journal of Clinical Gastroenterology. 47(2). 130–135. 49 indexed citations
6.
Gisbert, Javier P., Manuel Castro‐Fernández, Ángel Cosme, et al.. (2011). Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures. Gastroenterology. 140(5). S–878. 3 indexed citations
7.
Gisbert, Javier P., Fernando Bermejo, Pedro Almela, et al.. (2011). Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure. Time Trends of Eradication in a Spanish Multicenter Study of 830 Patients. Gastroenterology. 140(5). S–877. 2 indexed citations
8.
Castro‐Fernández, Manuel, et al.. (2009). Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori. Revista Española de Enfermedades Digestivas. 101(6). 395–8, 399. 23 indexed citations
9.
Gisbert, Javier P., Manuel Castro‐Fernández, Eloisa Lamas, et al.. (2008). M1073 Fourth-Line Rescue Therapy in Patients with Three H. pylori Eradication Failures. Gastroenterology. 134(4). A–332. 1 indexed citations
10.
Gisbert, Javier P., Manuel Castro‐Fernández, Fernando Bermejo, et al.. (2006). Third-Line Rescue Therapy with Levofloxacin After Two H. pylori Treatment Failures. The American Journal of Gastroenterology. 101(2). 243–247. 86 indexed citations
11.
Castro‐Fernández, Manuel, et al.. (2006). Influencia de los antiinflamatorios no esteroideos en la hemorragia digestiva por úlceras o erosiones gastroduodenales en pacientes con cirrosis hepática. Gastroenterología y Hepatología. 29(1). 11–14. 11 indexed citations
12.
Lobato, R.D., Rafael Escudero Alday, A. Cabrera, et al.. (2000). Asociaciones tumorales en el sistema nervioso central. Estudio de ocho casos con verificación quirúrgica. Neurocirugía. 11(1). 31–42. 1 indexed citations
13.
Muñoz, Gabriela, Marta Velasco Rodríguez‐Belvís, Javier Brahm, et al.. (1998). [Prevalence and genotypes of hepatitis C virus in blood donors and in patients with chronic liver disease and hepatocarcinoma in a Chilean population].. PubMed. 126(9). 1035–42. 18 indexed citations
14.
Lamas, Eloisa & Ricardo Pellón. (1993). Adquisición de polidipsia inducidad por programa en ratas con demoras dependientes de los lametones en la presentación de la comida. Dialnet (Universidad de la Rioja). 14(1). 75.
15.
Cordobés, F., R.D. Lobato, J.J. Rivas, et al.. (1981). OBSERVATIONS ON 82 PATIENTS WITH EXTRADURAL HEMATOMA. Journal of Computer Assisted Tomography. 5(4). 596–596. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026